N
NanoDimension
NanoDimension is a Series A to Series D stage investment firm. It has made 7 investments. Average disclosed round size is $31.4M (across 11 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
EM
Eric Moessinger
Partner
KK
Kirill Kuzmichev
Principal
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAlveo Energy | Series D | $35M | Jul 2020 |
| AAlveo Energy | Unknown | $13.7M | Nov 2019 |
| AAmphivena Therapeutics | Series C | $62M | Sep 2019 |
| AAmphivena | Series C | $62M | Sep 2019 |
| TTarveda Therapeutics | Series C | $38M | Jan 2016 |
 Emulate | Series B | $45M | Jan 2016 |
| AAlveo Energy | Unknown | $6.6M | Jan 2016 |
| Emulate | Series A | $12M | Jan 2014 |
 Selecta Biosciences | Series B | $25.3M | Feb 2009 |
| CCrocus Technology | Unknown | $15.8M | Jun 2008 |
| CCrocus Technology | Series A | — | Jun 2006 |
| TTarveda Therapeutics | Series D | $30M | — |
Top Co-Investors
Tekla Capital Management2 shared
Aju IB2 shared
MPM Capital2 shared
Founders Fund2 shared
Prelude Ventures2 shared
Khosla Ventures2 shared
AJU IB Investment1 shared
Korys1 shared
Flagship Ventures1 shared
Polaris Partners1 shared
Labcorp1 shared
OS Fund1 shared
Cedars-Sinai Medical Center1 shared
Volta Energy Technologies1 shared
ABB Ventures1 shared
Chevron Technology Ventures1 shared
New Enterprise Associates1 shared
Flagship Pioneering1 shared
Novo Holdings A/S1 shared
Versant Ventures1 shared
Last updated: 14 September 2026